巴西和联合王国的成年人在外观上使用不贴标签的减重药物,尽管没有医疗需要,但会危及健康。 Brazilian and UK adults use weight-loss drugs off-label for looks, risking health despite no medical need.

2024年,巴西律师加芙列拉(Gabriela)和英国行政主管安德鲁(Andrew)都拥有正常的BMIs和积极的生活方式,他们出于化妆原因开始使用Ozempic和Wegovy(Wegovy)等不贴标签的减重药品,在没有处方的情况下在网上获得这些药品。 In 2024, Brazilian lawyer Gabriela and UK executive Andrew, both with normal BMIs and active lifestyles, began using weight-loss drugs like Ozempic and Wegovy off-label for cosmetic reasons, obtaining them online without prescriptions. 尽管没有医疗需要,但他们报告说,食欲迅速抑制,体重下降,但根据外观、成本或社会事件、在吃或喝之前跳过剂量,药物循环循环或停止使用。 Despite no medical need, they reported rapid appetite suppression and weight loss but cycle on and off the medications based on appearance, cost, or social events, skipping doses before eating or drinking. 医生警告这种滥用有可能造成肌肉丧失和新陈代谢伤害,因为这些药物仅被批准用于肥胖症或2型糖尿病,而不是化妆品用途。 Doctors warn such misuse risks muscle loss and metabolic harm, as these drugs are approved only for obesity or type 2 diabetes, not cosmetic use.